“Hook Effect and Serum KL-6 in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)”. International Journal of Integrated Health Sciences, vol. 9, no. 2, Oct. 2021, pp. 66-72, https://doi.org/10.15850/ijihs.v9n2.2488.